Skip to content

The effect of Rosa damascena on anxiety and sexual function in breastfeeding women

The effect of Rosa damascena extract on anxiety and sexual function of primi parous breastfeeding women

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211015052775N1
Enrollment
94
Registered
2022-02-14
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: anxiety. Condition 2: Sexual dysfunction. Generalized anxiety disorder Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention group: At first, Rosa damascena petals will be purchased by a researcher from a reputable shop. Then the plant will be dried, ground and extracted by meceration method (so

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Breastfeeding At least 6 weeks up to 12 months after delivery Having a spouse Primiparous Single fetus Basic Literacy Scores less than 26 from the Sexual Function Questionnaire Scores 20-53 from the Spielberger questionnaire

Exclusion criteria

Exclusion criteria: History of allergy to Rosa damascana and its derivatives Specific disease of the breast and uterus Taking certain medications that affect sexual function (such as antidepressants, aspirin, and anticoagulants) Feeding the baby with formula Smoking or alcohol consumption5 Pregnancy A history of any mental illness or severe trauma in the last 6 months

Design outcomes

Primary

MeasureTime frame
Score less than 26.5 in the Sexual Function Questionnaire (FSFI) and a score of 53-20 from the overt anxiety questionnaire and a score of 20-53 from the hidden anxiety section (STAI). Timepoint: 8 weeks. Method of measurement: The Sexual Function Questionnaire (FSFI) and the overt and covert anxiety questionnaire (STAI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGohar Akbarzadeh

Ahvaz University of Medical Sciences

akbarzadeh.g@ajums.ac.ir+98 61 3373 8333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026